| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.00093 | 1 |